<table border="1"><tr><th>Surname</th><td><ul><li>Olanzapin</li></ul></td></tr><tr><th>Other names</th><td><ul><li>2-Methyl-10-(4-methylpiperazin-1-yl)-4 | H | -3-thia-4,9-diazabenzo[ | f | ]azoles (IUPAC) | Olanzapinum (Latin)</li></ul></td></tr><tr><th>Sum formula</th><td><ul><li>C | 17 | H | 20 | N | 4 | S</li></ul></td></tr><tr><th>Short description</th><td><ul><li>yellow, crystalline powder</li></ul></td></tr><tr><th>EC number</th><td><ul><li>603-618-4</li></ul></td></tr><tr><th>ECHA-InfoCard</th><td><ul><li>100.125.320</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>135398745</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB00334</li></ul></td></tr><tr><th>Wikidata</th><td><ul><li>Q201872</li></ul></td></tr><tr><th>ATC-Code</th><td><ul><li>N05 | AH03</li></ul></td></tr><tr><th>Class of active substances</th><td><ul><li>Atypical neuroleptics</li></ul></td></tr><tr><th>Mechanism of action</th><td><ul><li>D | 4 | –Rezeptor-Antagonist</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>312.43 g·mol | −1</li></ul></td></tr><tr><th>Aggregate state</th><td><ul><li>strong</li></ul></td></tr><tr><th>melting point</th><td><ul><li>195 °C</li></ul></td></tr><tr><th>p | K | S | -value</th><td><ul><li>4.69; 7.37</li></ul></td></tr><tr><th>Solubility</th><td><ul><li>practically soluble in water | easily soluble in diluted mineral acids</li></ul></td></tr><tr><th>GHS hazard labelling | Attention</th><td><ul><li></li></ul></td></tr><tr><th>H- and P-seeds</th><td><ul><li>H | 315 | ‐ | 319 | ‐ | 413</li></ul></td></tr><tr><th>General</th><td><ul><li>French name | Olanzapin | Other names | 2-Methyl-10-(4-methylpiperazin-1-yl)-4 | H | -3-thia-4,9-diazabenzo[ | f | ]azoles (IUPAC) | Olanzapinum (Latin) | Sum formula | C | 17 | H | 20 | N | 4 | S | Short description | yellow, crystalline powder</li></ul></td></tr><tr><th>External Identifiers/Databases</th><td><ul><li>CAS Number | 132539-06-1 | EC Number | 603-618-4 | ECHA InfoCard | 100.125.320 | PubChem | 135398745 | DrugBank | DB00334 | Wikidata | Q201872 | CAS Number | 132539-06-1 | EC Number | 603-618-4 | ECHA InfoCard | 100.125.320 | PubChem | 135398745 | DrugBank | DB00334 | Wikidata | Q201872 | CAS Number | 132539-06-1 | EC Number | 603-618-4 | ECHA InfoCard | 100.125.320 | PubChem | 135398745 | DrugBank | DB00334 | Wikidata | Q201872</li></ul></td></tr><tr><th>Drug Data</th><td><ul><li>ATC Code | N05 | AH03 | Active Class | Atypical Neuroleptics | Active Mechanism | D | 4 | –Rezeptor antagonist</li></ul></td></tr><tr><th>Properties</th><td><ul><li>Molar mass | 312.43 g·mol | −1 | aggregate state | solid | melting point | 195 °C | p | K | S | -value | 4.69; 7.37 | solubility | practically insoluble in water | slightly soluble in diluted mineral acids</li></ul></td></tr><tr><th>GHS hazard labelling</th><td><ul><li></li></ul></td></tr><tr><th>Safety Notes</th><td><ul><li>Please note the exemption from the labelling obligation for medicines, medical products, cosmetics, food and feed | H- and P-seats | H | 315 | ‐ | 319 | ‐ | 413 | P | 305 | ‐ | 351 | ‐ | 338 | Please note the exemption from the labelling obligation for medicines, medical products, cosmetics, food and feed | H | 315 | ‐ | 319 | ‐ | 413 | P | 305 | ‐ | 351 | ‐ | 338 | SI units are used as far as possible and as is customary. If not otherwise noted, the data indicated apply under standard conditions.</li></ul></td></tr></table>